Shanghai has established itself as a leading player in the global life sciences sector. JLL tapped into its global network of investors and knew that Concora would appreciate the park’s potential.
Life Science Industrial Park - development in Shanghai
Capital Markets
APAC
The heart of Shanghai’s pharma valley
The 54,466 square meter park was developed by Simcere Pharmaceutical Company in Zhangjiang Zhoupu and serves as its R&D headquarters.
When the company decided to sell, they turned to JLL to facilitate a deal and find a buyer that would understand and protect the specialist nature of the industrial park.
The asset comprises of one main building .and 17 other stand-alone properties, complemented by comprehensive amenities and green features.Tenants in business parks mainly engage in R&D activities related to AI+, innovative drugs and medical equipment.
Simcere Pharmaceutical Company itself is a leading pharmaceutical company in China with more than 6,500 employees.
“Life sciences investors have confidence in the long-term growth prospects of the industry and are interested in assets with anchor tenants or long WALE. Moreover, development opportunities for joint ventures between life sciences companies and investors will arise."
- Sun Ling, Head of Capital Markets, East China